But that doesn’t mean people are thrilled about it. According to the company, the generic version of the life-saving drug is on its way to pharmacies across America come next week.   The controversy over price-gouging though,  remains largely still in-tact.

Although, the cost-saving option for the drug will largely depend on which insurance a patient has and their eligibility for Mylan ‘s own assistance programs.  The insurance part, perhaps, making it much more difficult  for certain patients to actually take advantage of the cost-saving EpiPen pack.

 

(Visited 22 times, 1 visits today)
READ  Georgia man indicted on murder charges in death of Athens teenager
Categories: Your take?